Exhibit 10.1
VIRACTA THERAPEUTICS, INC. EXECUTIVE EMPLOYMENT AGREEMENT
This Employment Agreement (this “Agreement”) by and between Viracta Therapeutics, Inc. (the “Company”) and Michael E. Faerm (“Executive”) is effective as of May 13, 2024 (the “Effective Date”).
2
3
4
5
In no event will Executive have any discretion with respect to the ordering of payments or benefits.
6
7
8
9
Notices. All notices, requests, demands and other communications called for hereunder will be in writing and will be deemed given (i) on the date of delivery if delivered personally, (ii) one (1) day after being sent by a well established commercial overnight service, or (iii) four (4) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors at the following addresses, or at such other addresses as the parties may later designate in writing:
If to the Company:
Viracta Therapeutics, Inc.
2533 South Coast Highway 101, Suite 210
Cardiff, CA 92007
Attn: Chief Executive Officer
If to Executive:
at the last residential address known by the Company.
10
Remainder of Page Intentionally Left Blank
11
IN WITNESS WHEREOF, each of the parties has executed this Agreement (in the case of the Company, by a duly authorized officer or director), effective as of the Effective Date.
COMPANY:
VIRACTA THERAPEUTICS, INC.
/s/ Mark Rothera
By: Mark Rothera
Title: President & Chief Executive Officer
EXECUTIVE:
/s/ Michael E. Faerm
Michael E. Faerm
12